Jenavalve Technology, Inc.
Clinical trials sponsored by Jenavalve Technology, Inc., explained in plain language.
-
New heart valve procedure could offer a gentler option for leaky valve patients
Disease control Recruiting nowThis study tests a new, less invasive way to replace a leaky aortic heart valve (aortic regurgitation) using a device called the JenaValve Trilogy, compared to standard open-heart surgery. About 1,000 people with moderate to severe aortic regurgitation will be randomly assigned t…
Phase: NA • Sponsor: JenaValve Technology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New heart valve device could help patients with heart pumps avoid open surgery
Disease control Recruiting nowThis study is testing a new heart valve device (JenaValve Trilogy) placed through a tube in an artery, without open surgery. It is for 50 adults who have a mechanical heart pump (LVAD) and also a leaky aortic valve that makes the pump work less effectively. The goal is to see if …
Phase: NA • Sponsor: JenaValve Technology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC